FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Breakthrough Status for Alcyone Lifesciences ThecaFlex DRx

FDA grants Alcyone Lifesciences a breakthrough device designation for its ThecaFlex DRx System, an implantable subcutaneous port and intrathecal cathe...

FDA General

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 2/8/2019.

Federal Register

Comments Sought on Info Collection for CDRH Appeals

Federal Register notice: FDA seeks comments on an information collection extension for Center for Devices and Radiological Health Appeals Processes.

Federal Register

New Info Collection on Bio Product Name Suffix

Federal Register notice: FDA seeks comments on a new information collection for Proposed Suffix for the Proper Name of a Biological Product.

Federal Register

Draft Guide on Biologic Product Nonproprietary Naming

Federal Register notice: FDA makes available a draft guidance entitled Nonproprietary Naming of Biological Products: Update.

Marketing

FDA Plans Survey on Drug Promotion Targeted at Physicians

FDA seeks comments on a new information collection related to a proposed Healthcare Professional Survey of Professional Prescription Drug Promotion.

Medical Devices

Updated Alert on Surgical Stapler Safety

FDA issues a letter to health care providers to alert them to an increasing number of medical device reports associated with surgical staplers for int...

Human Drugs

American Health Packaging Recall of Valsartan

American Health Packaging recalls one lot of valsartan tablets,160 mg , due to the detection of trace amounts of an unexpected carcinogen in the finis...

Medical Devices

Zeiss Medical Technology 510(k) for Epithelial Mapping

FDA clears a Zeiss Medical Technology 510(k) for the Cirrus HD-OCT platform, expanding the capabilities of its anterior segment premier module to incl...

Human Drugs

Genentechs Tecentriq OKd for Breast Cancer

FDA grants Genentech accelerated approval for Tecentriq (atezolizumab) plus chemotherapy (Abraxane [paclitaxel protein-bound particles for injectable ...